Michael R. Narkewicz, Michael Green, Stephen Dunn, Michael Millis, Susan McDiarmid, George Mazariegos, Ravinder Anand, Wanrong Yin, Studies of Pediatric Liver Transplantation Research Group – 21 May 2013 – Posttransplant lymphoproliferative disorder (PTLD) causes significant morbidity and mortality in pediatric recipients of liver transplantation (LT). Objective: Describe the incidence of PTLD and symptomatic Epstein‐Barr virus (SEBV) disease in a large multicenter cohort of children who underwent LT with a focus on the risk factors and changes in incidence over time.

Seong Hoon Kim, Young Kyu Kim, Seung Duk Lee, Sang‐Jae Park – 21 May 2013 – The evidence for defining a safe minimal remnant volume after living donor hepatectomy is insufficient. The aim of this study was to evaluate the outcomes of living donors with a remnant/total volume ratio (RTVR) < 30% after right hepatectomy according to the following selection criteria: the preservation of the middle hepatic vein (MHV), an age < 50 years, and no or mild fatty changes in healthy adults.

Ibrahim A. Hanouneh, Bradley D. Confer, Nizar N. Zein, Naim Alkhouri, Bijan Eghtesad – 21 May 2013

Moritz Kleine, Florian W. R. Vondran, Kai Johanning, Kai Timrott, Hüseyin Bektas, Frank Lehner, Juergen Klempnauer, Harald Schrem – 21 May 2013 – Survival of critically ill patients is significantly affected by prolonged ventilation. The goal of this study was the development of a respiratory risk score (RRS) for the prediction of 3‐month mortality and prolonged ventilation after liver transplantation (LT). Two hundred fifty‐four consecutive LT patients from a single center were retrospectively randomized into a training group for model design and a validation group.

Ryan P. Cauley, Khashayar Vakili, Kristina Potanos, Nora Fullington, Dionne A. Graham, Jonathan A. Finkelstein, Heung Bae Kim – 21 May 2013 – Infants have the highest wait‐list mortality of all liver transplant candidates. Although previous studies have demonstrated that young children may be at increased risk when they receive partial grafts from adult and adolescent deceased donors (DDs), with few size‐matched organs available, these grafts have increasingly been used to expand the pediatric donor pool.

Yasutsugu Takada, Toshimi Kaido, Katsuhiro Asonuma, Hiroyuki Sakurai, Shoji Kubo, Tetsuya Kiuchi, Yukihiro Inomata, Shuji Isaji, Hayami Tsumura, Satoshi Teramukai, Yoshihiro Matsubara, Satomi Sakabayashi, Shinji Uemoto – 21 May 2013 – The purpose of this prospective, randomized, multicenter trial was to evaluate the effects of a steroid‐avoiding immunosuppression protocol on hepatitis C virus (HCV)–positive recipients of living donor liver transplantation (LDLT).

Ivo C. J. H. Post, Marcel C. Dirkes, Michal Heger, Joanne Verheij, Kora M. Bruin, Dirk Korte, Roelof J. Bennink, Thomas M. Gulik – 21 May 2013 – Donor graft washout can be impaired by colloids in organ preservation solutions that increase the viscosity and agglutinative propensity of red blood cells (RBCs) and potentially decrease organ function.

Milan Kinkhabwala, Joel Lindower, John F. Reinus, Anita L. Principe, Paul J. Gaglio – 21 May 2013 – The fate of donor livers allocated via an out‐of‐sequence expedited placement (EP) pathway has not been previously examined. We determined the originating and receiving United Network for Organ Sharing (UNOS) regions of all donor livers procured between January 1, 2010 and October 31, 2012 and placed out of sequence with UNOS bypass code 863 (EP attempt) or 898 (miscellaneous).

James F. Trotter, Monica Grafals, Angel E. Alsina – 21 May 2013 – Renal dysfunction is a critical issue for liver transplant candidates and recipients. Acute nephrotoxicity and chronic nephrotoxicity, however, are the compromises for the potent immunosuppression provided by calcineurin inhibitors (CNIs). To maintain the graft and patient survival afforded by CNIs while minimizing renal dysfunction in liver transplant patients, the reduction, delay, or elimination of CNIs in immunosuppression regimens is being implemented more frequently by clinicians.

Armin Finkenstedt, Karin Nachbaur, Heinz Zoller, Michael Joannidis, Johann Pratschke, Ivo W. Graziadei, Wolfgang Vogel – 21 May 2013 – Acute‐on‐chronic liver failure (ACLF) is characterized by high short‐term mortality. Liver transplantation (LT) is a potential therapy for patients who do not improve with supportive measures, but the efficacy of LT has not been shown. The aim of this study was to investigate the feasibility of LT and to determine the postoperative outcomes of patients with ACLF. All patients referred to our liver unit between 2002 and 2010 were registered in a database.